| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 62, 812-815, Copyright © 1986 by Endocrine Society
ARTICLES |
A Belanger, M Brochu and J Cliche
The levels of plasma dehydroepiandrosterone (DHEA), androst-5-ene-3 beta,17 beta-diol (delta 5-diol), testosterone (T), dihydrostestosterone (DHT), androstane-3 alpha,17 beta-diol (3 alpha- diol), androsterone (ADT), and the related glucuronide (G) derivatives were determined in intact and castrated men with prostatic cancer. The plasma concentrations of DHEA and DHEA-G were not significantly different in intact and castrated men while delta 5-diol as well as delta 5-diol-G were 50% lowered in castrated men. As expected, T and DHT concentrations were markedly lower in castrated men. These low plasma levels of T and DHT were accompanied by a decrease of 3 alpha- diol, ADT, T-G, 3 alpha-diol-G, and ADT-G levels. There was, in unoperated men, a positive correlation between the levels of DHEA and ADT-G as well as DHEA and DHEA-G, while T values were highly correlated with ADT-G and 3 alpha-diol-G levels. Furthermore, a significant relationship was found between DHEA and ADT-G as well as 3 alpha-diol-G in castrated men. Our data clearly demonstrate that ADT-G and 3 alpha- diol-G levels are more affected by castration than are the corresponding unconjugated steroids and suggest that these steroid glucuronides should be good markers of androgen metabolism. Moreover, the significant relationship between DHEA, ADT-G, and 3 alpha-diol-G in castrated men also suggests that approximately 30% of C-19 steroids from the adrenals are converted to T and DHT, which are further transformed into steroid glucuronides.
This article has been cited by other articles:
![]() |
K. Mai, T. Bobbert, V. Kullmann, J. Andres, H. Rochlitz, M. Osterhoff, M. O. Weickert, V. Bahr, M. Mohlig, A. F. H. Pfeiffer, et al. Free Fatty Acids Increase Androgen Precursors in Vivo J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1501 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mizokami, E. Koh, H. Fujita, Y. Maeda, M. Egawa, K. Koshida, S. Honma, E. T. Keller, and M. Namiki The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen Receptor Cancer Res., January 15, 2004; 64(2): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyamoto, P. Marwah, A. Marwah, H. Lardy, and C. Chang 3beta -Acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity PNAS, April 15, 2003; 100(8): 4440 - 4444. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Sun, S. P. Donald, and J. M. Phang Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells Carcinogenesis, November 1, 2001; 22(11): 1775 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barbier, C. Girard, L. Berger, M. El Alfy, A. Belanger, and D. W. Hum The Androgen-Conjugating Uridine Diphosphoglucuronosyltransferase-2B Enzymes Are Differentially Expressed Temporally and Spatially in the Monkey Follicle throughout the Menstrual Cycle Endocrinology, June 1, 2001; 142(6): 2499 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wu, A. S. Whittemore, L. N. Kolonel, F. Z. Stanczyk, E. M. John, R. P. Gallagher, and D. W. West Lifestyle Determinants of 5{{alpha}}-Reductase Metabolites in Older African-American, White, and Asian-American Men Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 533 - 538. [Abstract] [Full Text] |
||||
![]() |
H.-C. Chang, H. Miyamoto, P. Marwah, H. Lardy, S. Yeh, K.-E. Huang, and C. Chang Suppression of Delta 5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells PNAS, September 28, 1999; 96(20): 11173 - 11177. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levesque, M. Beaulieu, C. Guillemette, D. W. Hum, and A. Belanger Effect of Interleukins on UGT2B15 and UGT2B17 Steroid Uridine Diphosphate-Glucuronosyltransferase Expression and Activity in the LNCaP Cell Line Endocrinology, May 1, 1998; 139(5): 2375 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, A. Belanger, L. Cusan, J.-L. Gomez, and B. Candas Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites During Aging J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2396 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, A. Belanger, L. Cusan, and B. Candas Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2403 - 2409. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Young, B. Couzinet, K. Nahoul, S. Brailly, P. Chanson, E. E. Baulieu, and G. Schaison Panhypopituitarism as a Model to Study the Metabolism of Dehydroepiandrosterone (DHEA) in Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2578 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guillemette, E. Levesque, M. Beaulieu, D. Turgeon, D. W. Hum, and A. Belanger Differential Regulation of Two Uridine Diphospho-Glucuronosyltransferases, UGT2B15 and UGT2B17, in Human Prostate LNCaP Cells Endocrinology, July 1, 1997; 138(7): 2998 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tchernof, F. Labrie, A. Belanger, D. Prud'homme, C. Bouchard, A. Tremblay, A. Nadeau, and J.-P. Despres Androstane-3{alpha},17{beta}-Diol Glucuronide as a Steroid Correlate of Visceral Obesity in Men J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1528 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beaulieu, E. Levesque, D. W. Hum, and A. Belanger Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids J. Biol. Chem., September 13, 1996; 271(37): 22855 - 22862. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |